You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table GPS-3. Last year prevalence of drug use among all adults (aged 15 to 64 years old) in nationwide surveys among the general population

Country Geographical area		Year	Ref.	Age range all adults	Sample size all adults	Cannabis (%)	Cocaine (%) (1)	Amphet-amines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium
Vlaanderen (Brussels excluded)		1994	(1)	18-65	2259	1.5	0.2	0.3	0.1
French Community		1996-97	(2)	18-49	978
French Community		1998-99	(3)	18-49	1006
French Community		2000	(4)	18-49	693
National		2001	(5)	15-64	7347
National		2004	(6)	15-64		5.0
Bulgaria
National		2005	(1)	18-60	1036	1.5	0.3	0.4	0.5	0.2
Czech Republic
National		2002	(1)	18-64	2526	10.9		1.1	2.5	1.0
National		2004	(2)	18-64	3526	9.3	0.2	0.7	3.5	0.4
Denmark
National		1990	(1)	>=16	2000	5.0	0.2	0.7
National		1994	(2)
National		2000	(3)	16-64	11825	6.2	0.8	1.3	0.5	0.2
National		2005	(4)	16-64	13310	5.2	1.0	0.7	0.3	0.1
Germany
East Germany		1990	(1)
Western Germany		1990	(2)
Old and New Länder		1995	(3)	18-59	7833	4.4	0.8	0.7	0.8
Old and New Länder		1997	(4)	18-59	8019	4.0	0.6	0.4	0.8
National		2000	(5)	18-59	8139	6.0	0.9	0.6	0.7	0.2
National		2003	(6)	18-59	8061	6.9	1.0	0.9	0.8	0.3
Estonia
National		1998	(1)	18-64	2317	2.0		1.0
National		2003	(2)	15-64		4.6	0.6	1.3	1.7	0.3
Ireland
National		1998	(1)	18-64	826
National		1998	(2)	18-64		9.4	1.3	2.6	2.4	1.4
National		2000	(3)	18-64	907
National		2002-03	(4)	15-64	4918	5.0	1.1	0.4	1.1	0.1
Greece
Athens		1993	(1)	12-64	2103	2.5	0.2	0.1
National (except Aegean and Ionian Islands)		1998	(2)	15-64	3398	4.4	0.5	0.0	0.1
National (except Aegean and Ionian Islands)		2004	(3)	15-64	4351	1.7	0.1	0.0	0.2	0.1
Spain
National		1995	(1)	15-64	8888	7.3	1.9	1.1	1.3
National		1997	(2)	15-65	12515	7.6	1.7	0.9	0.9
National		1999	(3)	15-64	12234	7.0	1.6	0.7	0.8
National		2001	(4)	15-64	14113	9.7	2.6	1.2	1.9
National		2003	(5)	15-64	12033	11.3	2.7	0.8	1.4
National		2005-06	(6)	15-64	27934	11.2	3.0	0.7	1.2
France
National		1992	(1)	15-64	2099	3.9	0.3
Metropolitan France		1995	(2)	18-75	1787	4.7	0.2	0.3
National		1999	(3)	18-69	1742	7.4	0.2	0.1	0.2	0.1
National		2000	(4)	15-64	11317	8.4	0.2	0.2	0.2	0.2
Metropolitan France		2002	(5)	15-64	1744	9.8	0.3	0.0	0.3	0.1
National		2005	(6)	15-64	25879	8.6	0.6	0.1	0.4	0.1
Italy
National		2001	(1)	15-44	6032	6.2	1.1	0.1	0.2	0.0
National		2003	(2)	15-54	11869	7.1	1.2	0.2	0.4	0.2
National		2005	(3)	15-64	27995	11.2	2.2	0.4	0.5	0.6
Cyprus
National		2006	(1)	15-64	3504	2.1	0.6	0.3	1.0	0.5
Latvia
National		2003	(1)	15-64	4534	3.8	0.2	1.1	0.8	0.5
Lithuania
National		2004	(1)	15-64	4207	2.2	0.3	0.3	0.4	0.1
Luxembourg
National		1998	(1)	15-64		4.0	0.2		0.0
Hungary
National		2001	(1)	18-65	2359	2.4	0.7	0.7	0.8	0.7
National		2003	(2)	18-54		3.9	0.4	1.0	1.4	0.5
Malta
National		2001	(1)	18-64	1755	0.8	0.3	0.0	0.2	0.1
Netherlands
National	(4)	1997-98	(1)	15-64	17590	5.5	0.7	0.4	0.8
National	(4)	2001	(2)	15-64	2312	5.5	0.7	0.4	1.1	0.0
National		2005	(3)	15-64	4516	5.4	0.6	0.3	1.2	0.1
Austria
National		2004	(1)	15-64	3980	7.5	0.9	0.8	0.9	0.2
Poland
National		2002	(1)	16-64		2.8	0.5	0.7	0.2	0.4
Portugal
National		2001	(1)	15-64	14186	3.3	0.3	0.1	0.4	0.1
Romania
National		2004	(1)	15-64
Slovakia
National		2002	(1)	18-64	1405	3.6	0.6	0.2	0.8
National		2004	(2)	15-64	1315	4.1	0.5	0.3	1.2
Finland
National		1992	(1)	18-74	3457	1.2
National		1996	(2)	16-74	3009	1.9
National		1998	(3)	15-69	2568	2.5	0.2	0.2	0.2
National		2000	(4)	15-64	1677	2.2	0.2	0.4	0.3	0.2
National		2002	(5)	15-64	2377	2.9	0.3	0.5	0.5	0.1
National		2004	(6)	15-64	2352	2.9	0.3	0.6	0.5	0.1
Sweden
National		1994	(1)	16-64	806
National		1996	(2)	16-64	1136
National		1998	(3)	16-64	1359	0.9	0.1	0.1	0.0
National		2000	(4)	16-64	1750	0.7	0.0	0.2	0.2	0.0
National		2004	(5)	18-64	9514	2.2
National		2005	(6)	16-64	30538	2.0
National		2006	(7)	16-64	41701	2.0
United Kingdom
England and Wales		1994	(1)	16-59	9645	8.4	0.5	2.4	1.0	1.3
England and Wales		1996	(2)	16-59	10935	9.5	0.6	3.2	1.7	1.0
England and Wales		1998	(3)	16-59	9984	10.3	1.3	3.0	1.5	0.8
England and Wales		2000	(4)	16-59	13018	10.5	2.0	2.1	1.8	0.7
England and Wales		2001-02	(5)	16-59	20165	10.6	2.0	1.6	2.2	0.3
England and Wales		2002-03	(6)	16-59	23586	10.9	2.1	1.6	2.0	0.3
England and Wales		2003-04	(7)	16-59	24422	10.8	2.5	1.5	2.0	0.2
England and Wales		2004-05	(8)	16-59	28509	9.7	2.0	1.4	1.8	0.2
England and Wales		2005-06	(9)	16-59	29748	8.7	2.4	1.3	1.6	0.3
Northern Ireland		2002-03	(10)	15-64	3516	5.4	0.5	0.8	1.6	0.1
Scotland		2003	(11)	16-64	3506	7.4	1.4	1.3	1.5	0.1
Scotland		2004	(12)	16-64	3293	5.8	1.4	0.9	1.0	0.2
United Kingdom		2004	(13)			10.3	2.3	1.5	1.9	0.2
Norway
National		1999	(1)	15-64	1803	4.5	0.6	1.2	0.7
National		2004	(2)	15-64	2669	4.6	0.8	1.1	0.5	0.2

Notes:

(1) Cocaine any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy.

(3) For Spain: ecstasy and other designer drugs.

(4) In the Netherlands the figures for 2001 have been recomputed using only the interviews conducted with CAPI method (Computer Assisted Personal Interview) and excluding other methods of data collection (mail, telephone, etc.) to ensure comparability with 1997 and 2005. For 2005, only respondents with information collected through the CAPI method were included (this note applies to all tables and graphics regarding population surveys for the Netherlands 2001 and 2005).

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions see General population surveys of drug use – methods and definitions.

For survey methods see Table GPS-1 part (ii).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.